No significant increase of either myelocytes or T cells was observed in peripheral blood when melanoma mice were co-inoculated with normal BMSCs or BMSCs pretreated with IL-17 or IFNγ individually (Figure 1D). This evidence concerns the gene IL17A and melanoma.